Vincerx Pharma Inc.
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 28 institutions reported holding Vincerx Pharma Inc. in their 13F filings, down 10 from Q1 2024. 4 opened new positions and 15 sold out. The largest holders were Prosight Management, LP ($2.0M), Armistice Capital, LLC ($1.6M) and Sage Rhino Capital LLC ($1.4M). 4 famous investors held it, including Steve Cohen (0.0% of Point72 Asset Management's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Vincerx Pharma Inc.
- CUSIP
- 92731L106
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $3.7M |
| Exits | 15 | $8.6M |
All 13F filers, Q1 2024 → Q2 2024: 4,990,285 shares bought and 2,754,740 shares sold, net +2,235,545 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 28 holders
| Prosight Management, LP | 0.60% | New | 2,488,418 | $2.0M |
| Armistice Capital, LLC | 0.04% | New | 1,988,000 | $1.6M |
| Sage Rhino Capital LLC | 0.33% | No change | 1,703,413 | $1.4M |
| Rock Springs Capital Management LP | 0.02% | No change | 891,719 | $722K |
| Point72 Asset Management | 0.00% | Reduce -29.4% | 674,193 | $546K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -0.0% | 631,421 | $511K |
| Vanguard Group Inc. | 0.00% | Reduce -5.9% | 627,442 | $508K |
| ExodusPoint Capital Management, LP | 0.00% | Add +50.9% | 477,954 | $387K |
| Marshall Wace, LLP | 0.00% | Add +359.1% | 328,533 | $266K |
| Geode Capital Management, LLC | 0.00% | Add +26.5% | 230,785 | $187K |
| Citadel Advisors | 0.00% | No change | 178,240 | $144K |
| Renaissance Technologies | 0.00% | Add +7.2% | 130,122 | $105K |
| Rubric Capital Management LP | 0.00% | No change | 116,873 | $95K |
| State Street Corp. | 0.00% | No change | 57,016 | $46K |
| BlackRock Inc. | 0.00% | No change | 47,080 | $38K |
| Northern Trust Corp. | 0.00% | Reduce -0.1% | 34,297 | $28K |
| XTX Topco Ltd | 0.00% | New | 18,181 | $15K |
| Two Sigma Investments, LP | 0.00% | New | 17,023 | $14K |
| Millennium Management | 0.00% | Reduce -55.9% | 11,445 | $9K |
| LPL Financial LLC | 0.00% | Reduce -25.4% | 10,270 | $8K |
| LMR Partners LLP | 0.00% | No change | 10,000 | $8K |
| Focus Partners Wealth | 0.00% | No change | 10,900 | $8K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +74.0% | 7,901 | $6K |
| Morgan Stanley | 0.00% | Reduce -91.1% | 1,750 | $1K |
| Bank & Trust Co | 0.00% | — | 1,000 | $810 |
| Bank of America Corp. | 0.00% | Reduce -100.0% | 210 | $170 |
| Qube Research & Technologies Ltd | 0.00% | Reduce -99.8% | 4 | $4 |
| UBS Group AG | 0.00% | Reduce -100.0% | 1 | $1 |
"% of holder's portfolio" is VINCERX PHARMA INC's weight in each manager's 13F, not the share of Vincerx Pharma Inc. the manager owns.